Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker?
Academic Article
Publication Date:
2017
Short description:
Concomitant monitoring of WT1 and FLT3-ITD expression in FLT3-ITD acute myeloid leukemia patients: which should we trust as a minimal residual disease marker? / De Marchi, F.; Candoni, A.; Zannier, M. E.; Haley, L.; Lau, B. W. Y.; Fanin, R.. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 92:5(2017), pp. E72-E74. [10.1002/ajh.24686]
Iris type:
Articolo su rivista
List of contributors:
De Marchi, F.; Candoni, A.; Zannier, M. E.; Haley, L.; Lau, B. W. Y.; Fanin, R.
Published in: